Home

Costa poco antenna Offesa lxr agonist clinical trial giungla Guerriero Nuovo arrivo

Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ  Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid  Precursor Protein/Presenilin 1 Mice* - Journal of Biological Chemistry
Combined Liver X Receptor/Peroxisome Proliferator-activated Receptor γ Agonist Treatment Reduces Amyloid β Levels and Improves Behavior in Amyloid Precursor Protein/Presenilin 1 Mice* - Journal of Biological Chemistry

Liver X receptors in lipid metabolism: opportunities for drug discovery -  Document - Gale Academic OneFile
Liver X receptors in lipid metabolism: opportunities for drug discovery - Document - Gale Academic OneFile

Frontiers | EGFR/FOXO3A/LXR-α Axis Promotes Prostate Cancer Proliferation  and Metastasis and Dual-Targeting LXR-α/EGFR Shows Synthetic Lethality |  Oncology
Frontiers | EGFR/FOXO3A/LXR-α Axis Promotes Prostate Cancer Proliferation and Metastasis and Dual-Targeting LXR-α/EGFR Shows Synthetic Lethality | Oncology

Liver X receptors in lipid metabolism: opportunities for drug discovery |  Nature Reviews Drug Discovery
Liver X receptors in lipid metabolism: opportunities for drug discovery | Nature Reviews Drug Discovery

LXR-inverse agonism stimulates immune-mediated tumor destruction by  enhancing CD8 T-cell activity in triple negative breast cancer | Scientific  Reports
LXR-inverse agonism stimulates immune-mediated tumor destruction by enhancing CD8 T-cell activity in triple negative breast cancer | Scientific Reports

Natural products as modulators of the nuclear receptors and metabolic  sensors LXR, FXR and RXR - ScienceDirect
Natural products as modulators of the nuclear receptors and metabolic sensors LXR, FXR and RXR - ScienceDirect

Liver X Receptor Agonist AZ876 Induces Beneficial Endogenous Cardiac Lipid  Reprogramming and Protects Against Isoproterenol‐Induced Cardiac Damage |  Journal of the American Heart Association
Liver X Receptor Agonist AZ876 Induces Beneficial Endogenous Cardiac Lipid Reprogramming and Protects Against Isoproterenol‐Induced Cardiac Damage | Journal of the American Heart Association

Molecules | Free Full-Text | Ligands of Therapeutic Utility for the Liver X  Receptors | HTML
Molecules | Free Full-Text | Ligands of Therapeutic Utility for the Liver X Receptors | HTML

Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear  Receptors PPARs, FXR, and LXR in NASH - Cellular and Molecular  Gastroenterology and Hepatology
Transcriptional Regulation of Metabolic Pathways via Lipid-Sensing Nuclear Receptors PPARs, FXR, and LXR in NASH - Cellular and Molecular Gastroenterology and Hepatology

Liver X Receptor Agonists as Potential Therapeutic Agents for Dyslipidemia  and Atherosclerosis | Arteriosclerosis, Thrombosis, and Vascular Biology
Liver X Receptor Agonists as Potential Therapeutic Agents for Dyslipidemia and Atherosclerosis | Arteriosclerosis, Thrombosis, and Vascular Biology

Screening for liver X receptor modulators: Where are we and for what use? -  Buñay - 2021 - British Journal of Pharmacology - Wiley Online Library
Screening for liver X receptor modulators: Where are we and for what use? - Buñay - 2021 - British Journal of Pharmacology - Wiley Online Library

LXR agonist T0901317 down-regulates the hepatic gluconeogenesis pathway...  | Download Scientific Diagram
LXR agonist T0901317 down-regulates the hepatic gluconeogenesis pathway... | Download Scientific Diagram

Approved LXR agonists exert unspecific effects on pancreatic β-cell  function | SpringerLink
Approved LXR agonists exert unspecific effects on pancreatic β-cell function | SpringerLink

Liver X receptors and fat cell metabolism | International Journal of Obesity
Liver X receptors and fat cell metabolism | International Journal of Obesity

Liver X receptors as potential targets for cancer therapeutics (Review)
Liver X receptors as potential targets for cancer therapeutics (Review)

Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X  Receptors Agonist Promotes Atherosclerosis Regression - eBioMedicine
Synthetic High-Density Lipoprotein-Mediated Targeted Delivery of Liver X Receptors Agonist Promotes Atherosclerosis Regression - eBioMedicine

An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers  - ScienceDirect
An LXR-Cholesterol Axis Creates a Metabolic Co-Dependency for Brain Cancers - ScienceDirect

Liver X receptors link lipid metabolism and inflammation - Schulman - 2017  - FEBS Letters - Wiley Online Library
Liver X receptors link lipid metabolism and inflammation - Schulman - 2017 - FEBS Letters - Wiley Online Library

Liver x receptor alpha drives chemoresistance in response to side-chain  hydroxycholesterols in triple negative breast cancer | Oncogene
Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer | Oncogene

Targeted Delivery of LXR Agonist Using a Site-Specific Antibody–Drug  Conjugate | Bioconjugate Chemistry
Targeted Delivery of LXR Agonist Using a Site-Specific Antibody–Drug Conjugate | Bioconjugate Chemistry

LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases  | SpringerLink
LXR Agonists: New Potential Therapeutic Drug for Neurodegenerative Diseases | SpringerLink

Approved LXR agonists exert unspecific effects on pancreatic β-cell  function | SpringerLink
Approved LXR agonists exert unspecific effects on pancreatic β-cell function | SpringerLink

Effect of LXR agonist on key inflammatory mediators in human pancreatic...  | Download Scientific Diagram
Effect of LXR agonist on key inflammatory mediators in human pancreatic... | Download Scientific Diagram

Cancers | Free Full-Text | Activation of LXR Receptors and Inhibition of  TRAP1 Causes Synthetic Lethality in Solid Tumors | HTML
Cancers | Free Full-Text | Activation of LXR Receptors and Inhibition of TRAP1 Causes Synthetic Lethality in Solid Tumors | HTML

Approved LXR agonists exert unspecific effects on pancreatic β-cell  function | SpringerLink
Approved LXR agonists exert unspecific effects on pancreatic β-cell function | SpringerLink